Skip to content
value.today

Stroma Medical Corp

Formerly Lumineyes, Inc.

Total raised
$43 M
2 rounds on record
Latest round
$39 M
Mar 2021
First round on record
May 2012
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Stroma Medical Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2021$39 MNo. 2$10 to $50 million

Stroma Medical Corp: Raise no. 2, Mar 2021

Investors in this round

144 investors had bought by the notice of Jun 16, 2023: 130 accredited, 14 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$39 M of $44 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: "Offering of Series B-1 and B-2 (""Series B Preferred Stock"") and the underlying shares of Common Stock issuable upon conversion of Series B Preferred Stock."
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Afshin Nadershahi · Executive Officer, Director, Promoter
  • Gregg Homer · Executive Officer, Director, Promoter
  • Baseer Khan · Director
  • J Andrew Corley · Director
  • Stephen Slade · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Items 13(a) and 13(b) include the conversion of outstanding convertible promissory notes in the aggregate amount of $3,368,000 previously reported on a Form D.”

Signed by Afshin Nadershahi, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 16, 2023. Read the notice at the SEC.

equitySEC
May 2012$4 MNo. 1$2 to $10 million

Stroma Medical Corp: Raise no. 1, May 2012

Investors in this round

37 investors had bought by the notice of Nov 13, 2014: 36 accredited, 1 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bruce Andy Feuchter · Executive Officer
  • Douglas Daniels · Executive Officer, Director
  • Gregg Homer · Executive Officer, Director
  • Edward Peterson · Director
  • J. Andy Corley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Promissory Note Extension”

Signed by Bruce Feuchter, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Nov 13, 2014. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Stroma Medical Corp chose not to state its revenue in its newest notice of a funding round (Jun 2023).

    SEC Form D · Jun 2023

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jun 2023

That is all the official record says: Stroma Medical Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Stroma Medical Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 144 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Stroma Medical Corp
NameRoleNamed in
Afshin NadershahiExecutive officerJun 2023
Gregg HomerExecutive officerJun 2023
Bruce Andy FeuchterExecutive officerNov 2014
Douglas DanielsExecutive officerNov 2014
Afshin NadershahiDirectorJun 2023
Baseer KhanDirectorJun 2023
Gregg HomerDirectorJun 2023
J Andrew CorleyDirectorJun 2023
Stephen SladeDirectorJun 2023
Douglas DanielsDirectorNov 2014
Edward PetersonDirectorNov 2014
J. Andy CorleyDirectorNov 2014
Afshin NadershahiPromoterJun 2023
Gregg HomerPromoterJun 2023